0001415889-22-010919.txt : 20221031
0001415889-22-010919.hdr.sgml : 20221031
20221031174450
ACCESSION NUMBER: 0001415889-22-010919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221027
FILED AS OF DATE: 20221031
DATE AS OF CHANGE: 20221031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STARKS DANIEL J
CENTRAL INDEX KEY: 0000902132
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 221347498
MAIL ADDRESS:
STREET 1: ONE ST JUDE MEDICAL DRIVE
CITY: ST PAUL
STATE: MN
ZIP: 55117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-10312022_021041.xml
X0306
4
2022-10-27
0000001800
ABBOTT LABORATORIES
ABT
0000902132
STARKS DANIEL J
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
true
false
false
false
Common shares without par value
2022-10-27
4
S
0
40687
97.3036
D
6882813
D
Common shares without par value
2022-10-27
4
S
0
9313
98.136
D
6873500
D
Common shares without par value
258
I
Alynne Starks 2012 Irrevocable Trust
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.82 to $97.80, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.82 to $98.67, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
/s/ Daniel J. Starks by Jessica H. Paik, Attorney-in-Fact
2022-10-31